淋巴细胞-话题@MedSci

#淋巴细胞#

495篇内容 | 7113人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1302306, encodeId=105213023063f, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Cancer Discorvery：科学家揭秘诱发急性淋巴细胞白血病复发的细胞特性, objectType=article, longId=190897, objectId=7b2119089e77, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b2119089e77, replyNumber=0, likeNumber=55, createdTime=2020-03-28, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b2119089e77, moduleTitle=Cancer Discorvery：科学家揭秘诱发急性淋巴细胞白血病复发的细胞特性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b2119089e77)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302305, encodeId=ef0613023052e, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Cell Death Dis：Nfkbie缺乏增加B淋巴细胞增生性疾病的易感性, objectType=article, longId=190575, objectId=398b1905e5d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=398b1905e5d3, replyNumber=0, likeNumber=54, createdTime=2020-03-23, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=398b1905e5d3, moduleTitle=Cell Death Dis：Nfkbie缺乏增加B淋巴细胞增生性疾病的易感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=398b1905e5d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302304, encodeId=cd87130230479, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=BCL-2抑制剂VENCLYXTO与CD20单抗obinutuzumab的联合疗法获欧洲批准，用于未经治疗的慢性淋巴细胞白血病, objectType=article, longId=190017, objectId=0f0519001e6d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f0519001e6d, replyNumber=0, likeNumber=79, createdTime=2020-03-16, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f0519001e6d, moduleTitle=BCL-2抑制剂VENCLYXTO与CD20单抗obinutuzumab的联合疗法获欧洲批准，用于未经治疗的慢性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f0519001e6d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302303, encodeId=3db91302303e6, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=建议采用肺保护性通气策略！新冠肺炎第7版诊疗方案发布：抗体检测纳入诊断标准，淋巴细胞下降和炎症因子升高，提示病情危重！, objectType=article, longId=189516, objectId=662a18951660, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=662a18951660, replyNumber=0, likeNumber=69, createdTime=2020-03-08, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=662a18951660, moduleTitle=建议采用肺保护性通气策略！新冠肺炎第7版诊疗方案发布：抗体检测纳入诊断标准，淋巴细胞下降和炎症因子升高，提示病情危重！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=662a18951660)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302302, encodeId=a968130230215, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Blood：一种新的儿童急性淋巴细胞白血病风险分层方法, objectType=article, longId=188246, objectId=11c418824652, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11c418824652, replyNumber=0, likeNumber=139, createdTime=2020-02-18, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11c418824652, moduleTitle=Blood：一种新的儿童急性淋巴细胞白血病风险分层方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11c418824652)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302301, encodeId=5dbf130230159, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=BMC Gastroenterology：血小板与淋巴细胞比例对胃癌总体生存的预后作用, objectType=article, longId=188235, objectId=d9b418823543, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9b418823543, replyNumber=0, likeNumber=49, createdTime=2020-02-18, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9b418823543, moduleTitle=BMC Gastroenterology：血小板与淋巴细胞比例对胃癌总体生存的预后作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9b418823543)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302300, encodeId=40ff130230068, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=MedRvix：年龄≥50岁且淋巴细胞明显降低的新冠肺炎，应尽快收入重症监护室, objectType=article, longId=188129, objectId=910e18812982, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=910e18812982, replyNumber=0, likeNumber=108, createdTime=2020-02-16, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=910e18812982, moduleTitle=MedRvix：年龄≥50岁且淋巴细胞明显降低的新冠肺炎，应尽快收入重症监护室, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=910e18812982)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302299, encodeId=e704130229917, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=KSQ Therapeutics发现潜在活性优于PD-1的基因靶标，可用于开发针对性的工程化肿瘤浸润淋巴细胞（eTIL）治疗难治性实体瘤, objectType=article, longId=187862, objectId=f68418e862d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f68418e862d3, replyNumber=0, likeNumber=54, createdTime=2020-02-13, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f68418e862d3, moduleTitle=KSQ Therapeutics发现潜在活性优于PD-1的基因靶标，可用于开发针对性的工程化肿瘤浸润淋巴细胞（eTIL）治疗难治性实体瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f68418e862d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302298, encodeId=56811302298fa, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=2020年ASCO-SITC：中性粒细胞与淋巴细胞的比例可预测晚期NSCLC患者接受免疫治疗的存活率, objectType=article, longId=187767, objectId=e71318e76739, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e71318e76739, replyNumber=0, likeNumber=94, createdTime=2020-02-11, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e71318e76739, moduleTitle=2020年ASCO-SITC：中性粒细胞与淋巴细胞的比例可预测晚期NSCLC患者接受免疫治疗的存活率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e71318e76739)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302297, encodeId=9008130229e22, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Clinica Chimica Acta：血液学参数、血小板与淋巴细胞比值、血红蛋白与血小板比值对结肠癌的诊断价值如何？, objectType=article, longId=187631, objectId=9a6018e6311e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a6018e6311e, replyNumber=0, likeNumber=85, createdTime=2020-02-08, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a6018e6311e, moduleTitle=Clinica Chimica Acta：血液学参数、血小板与淋巴细胞比值、血红蛋白与血小板比值对结肠癌的诊断价值如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a6018e6311e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302296, encodeId=7c2513022961d, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Blood：CD49d促进慢性淋巴细胞白血病进展, objectType=article, longId=187614, objectId=364e18e61427, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=364e18e61427, replyNumber=0, likeNumber=63, createdTime=2020-02-08, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=364e18e61427, moduleTitle=Blood：CD49d促进慢性淋巴细胞白血病进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=364e18e61427)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302295, encodeId=1aa6130229592, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Blood：亚克隆NT5C2突变与急性淋巴细胞白血病复发后的预后不良的相关性, objectType=article, longId=187564, objectId=83f918e56435, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83f918e56435, replyNumber=0, likeNumber=42, createdTime=2020-02-07, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83f918e56435, moduleTitle=Blood：亚克隆NT5C2突变与急性淋巴细胞白血病复发后的预后不良的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83f918e56435)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302294, encodeId=071313022942f, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=对于未经治疗的慢性淋巴细胞白血病患者，AbbVie的BCL-2抑制剂VENCLYXTO联合CD20单抗获得欧洲人用药物委员会的正面评价, objectType=article, longId=187245, objectId=3b7518e245e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b7518e245e4, replyNumber=0, likeNumber=78, createdTime=2020-02-04, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b7518e245e4, moduleTitle=对于未经治疗的慢性淋巴细胞白血病患者，AbbVie的BCL-2抑制剂VENCLYXTO联合CD20单抗获得欧洲人用药物委员会的正面评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b7518e245e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302293, encodeId=85d113022932c, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=有合并症的老年男士要警惕！《柳叶刀》研究：免疫功能低下者或需预防性使用抗生素，淋巴细胞减少可以作为新冠肺炎诊断参考指标, objectType=article, longId=187203, objectId=557418e20364, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=557418e20364, replyNumber=0, likeNumber=123, createdTime=2020-02-03, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=557418e20364, moduleTitle=有合并症的老年男士要警惕！《柳叶刀》研究：免疫功能低下者或需预防性使用抗生素，淋巴细胞减少可以作为新冠肺炎诊断参考指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=557418e20364)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302292, encodeId=8dd7130229296, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=NCCN临床实践指南：急性淋巴细胞白血病（2020.V1）, objectType=article, longId=186751, objectId=9796186e51b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9796186e51b4, replyNumber=0, likeNumber=19, createdTime=2020-01-27, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9796186e51b4, moduleTitle=NCCN临床实践指南：急性淋巴细胞白血病（2020.V1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9796186e51b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302291, encodeId=d8f613022916c, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=JAMA子刊研究称，淋巴细胞少，死亡风险高, objectType=article, longId=186283, objectId=41ca186283ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41ca186283ef, replyNumber=0, likeNumber=54, createdTime=2020-01-16, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41ca186283ef, moduleTitle=JAMA子刊研究称，淋巴细胞少，死亡风险高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41ca186283ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302290, encodeId=dd981302290e3, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=李建勇教授 | 经典药物焕新春，浅谈慢性淋巴细胞白血病的治疗, objectType=article, longId=186264, objectId=e25718626473, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e25718626473, replyNumber=0, likeNumber=76, createdTime=2020-01-16, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e25718626473, moduleTitle=李建勇教授 | 经典药物焕新春，浅谈慢性淋巴细胞白血病的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e25718626473)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302289, encodeId=a888130228995, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=李建勇教授：经典药物焕新春，浅谈慢性淋巴细胞白血病的治疗, objectType=article, longId=186262, objectId=bdf5186262fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdf5186262fb, replyNumber=0, likeNumber=80, createdTime=2020-01-16, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdf5186262fb, moduleTitle=李建勇教授：经典药物焕新春，浅谈慢性淋巴细胞白血病的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdf5186262fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302288, encodeId=c2ff13022888d, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Semin Arthritis Rheu：类风湿性关节炎中性粒细胞-淋巴细胞比率及其预测三联疗法失败的能力, objectType=article, longId=185923, objectId=73c11859238f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73c11859238f, replyNumber=0, likeNumber=64, createdTime=2020-01-10, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73c11859238f, moduleTitle=Semin Arthritis Rheu：类风湿性关节炎中性粒细胞-淋巴细胞比率及其预测三联疗法失败的能力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73c11859238f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302287, encodeId=b297130228efd, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Exp Ther Med：2型先天淋巴细胞在过敏性鼻炎儿科患者中表达增加, objectType=article, longId=185876, objectId=0bbe1858e6c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bbe1858e6c8, replyNumber=0, likeNumber=76, createdTime=2020-01-09, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bbe1858e6c8, moduleTitle=Exp Ther Med：2型先天淋巴细胞在过敏性鼻炎儿科患者中表达增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bbe1858e6c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

淋巴细胞

2020-05-29

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Cancer Discorvery：科学家揭秘诱发急性淋巴细胞白血病复发的细胞特性

2020-03-28

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Cell Death Dis：Nfkbie缺乏增加B淋巴细胞增生性疾病的易感性

2020-03-23

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

BCL-2抑制剂VENCLYXTO与CD20单抗obinutuzumab的联合疗法获欧洲批准，用于未经治疗的慢性淋巴细胞白血病

2020-03-16

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

建议采用肺保护性通气策略！新冠肺炎第7版诊疗方案发布：抗体检测纳入诊断标准，淋巴细胞下降和炎症因子升高，提示病情危重！

2020-03-08

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Blood：一种新的儿童急性淋巴细胞白血病风险分层方法

2020-02-18

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

BMC Gastroenterology：血小板与淋巴细胞比例对胃癌总体生存的预后作用

2020-02-18

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

MedRvix：年龄≥50岁且淋巴细胞明显降低的新冠肺炎，应尽快收入重症监护室

2020-02-16

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

KSQ Therapeutics发现潜在活性优于PD-1的基因靶标，可用于开发针对性的工程化肿瘤浸润淋巴细胞（eTIL）治疗难治性实体瘤

2020-02-13

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

2020年ASCO-SITC：中性粒细胞与淋巴细胞的比例可预测晚期NSCLC患者接受免疫治疗的存活率

2020-02-11

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Clinica Chimica Acta：血液学参数、血小板与淋巴细胞比值、血红蛋白与血小板比值对结肠癌的诊断价值如何？

2020-02-08

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Blood：CD49d促进慢性淋巴细胞白血病进展

2020-02-08

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Blood：亚克隆NT5C2突变与急性淋巴细胞白血病复发后的预后不良的相关性

2020-02-07

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

对于未经治疗的慢性淋巴细胞白血病患者，AbbVie的BCL-2抑制剂VENCLYXTO联合CD20单抗获得欧洲人用药物委员会的正面评价

2020-02-04

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

有合并症的老年男士要警惕！《柳叶刀》研究：免疫功能低下者或需预防性使用抗生素，淋巴细胞减少可以作为新冠肺炎诊断参考指标

2020-02-03

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

NCCN临床实践指南：急性淋巴细胞白血病（2020.V1）

2020-01-27

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

JAMA子刊研究称，淋巴细胞少，死亡风险高

2020-01-16

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

李建勇教授 | 经典药物焕新春，浅谈慢性淋巴细胞白血病的治疗

2020-01-16

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

李建勇教授：经典药物焕新春，浅谈慢性淋巴细胞白血病的治疗

2020-01-16

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Semin Arthritis Rheu：类风湿性关节炎中性粒细胞-淋巴细胞比率及其预测三联疗法失败的能力

2020-01-10

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Exp Ther Med：2型先天淋巴细胞在过敏性鼻炎儿科患者中表达增加

2020-01-09

科室
- - 订阅+
  - 更多科室
工具
服务